History of oncolytic viruses: Genesis to genetic engineering

被引:522
作者
Kelly, Elizabeth [1 ]
Russell, Stephen J. [1 ]
机构
[1] Mayo Clin, Coll Med, Program Mol Med, Rochester, MN 55905 USA
关键词
D O I
10.1038/sj.mt.6300108
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Since the turn of the nineteenth century, when their existence was first recognized, viruses have attracted considerable interest as possible agents of tumor destruction. Early case reports emphasized regression of cancers during naturally acquired virus infections, providing the basis for clinical trials where body fluids containing human or animal viruses were used to transmit infections to cancer patients. Most often the viruses were arrested by the host immune system and failed to impact tumor growth, but sometimes, in immunosuppressed patients, infection persisted and tumors regressed, although morbidity as a result of the infection of normal tissues was unacceptable. With the advent of rodent models and new methods for virus propagation, there were numerous attempts through the 1950s and 1960s to force the evolution of viruses with greater tumor specificity, but success was limited and many researchers abandoned the field. Technology employing reverse genetics later brought about a renewal of interest in virotherapy that allowed the generation of more potent, tumor-specific oncolytics. Here, examination of early oncolytic virotherapy before genetic engineering serves to highlight tremendous advances, yet also hints at ways to penetrate host immune defenses, a significant remaining challenge in modern virotherapy research.
引用
收藏
页码:651 / 659
页数:9
相关论文
共 131 条
[1]   Oncolytic viral therapies - the clinical experience [J].
Aghi, M ;
Martuza, RL .
ONCOGENE, 2005, 24 (52) :7802-7816
[2]   Replicative adenoviruses for cancer therapy [J].
Alemany, R ;
Balagué, C ;
Curiel, DT .
NATURE BIOTECHNOLOGY, 2000, 18 (07) :723-727
[3]   PROSPECTS FOR HUMAN-GENE THERAPY [J].
ANDERSON, WF .
SCIENCE, 1984, 226 (4673) :401-409
[4]   HUMAN GENE-THERAPY [J].
ANDERSON, WF .
SCIENCE, 1992, 256 (5058) :808-813
[5]  
[Anonymous], 1957, BMJ-BRIT MED J, V2, P1481
[6]  
ASADA T, 1974, CANCER, V34, P1907, DOI 10.1002/1097-0142(197412)34:6<1907::AID-CNCR2820340609>3.0.CO
[7]  
2-4
[8]   VIRAL RNA-DEPENDENT DNA POLYMERASE - RNA-DEPENDENT DNA POLYMERASE IN VIRIONS OF RNA TUMOUR VIRUSES [J].
BALTIMORE, D .
NATURE, 1970, 226 (5252) :1209-+
[9]  
Beijerinck M. W., 1898, Verhandelingen der Koninklijke Nederlandsche Akademie van Wetenschappen. Afdeeling Natuurkunde, V5, P3
[10]   Timeline - Radiation oncology: a century of achievements [J].
Bernier, J ;
Hall, EJ ;
Giaccia, A .
NATURE REVIEWS CANCER, 2004, 4 (09) :737-U15